Abstract: Spatiotemporal control over biochemical signaling processes involving Gp rotein-coupled receptors (GPCRs) is highly desired for dissecting their complex intracellular signaling. We developed sixteen photoswitchable ligands for the human histamine H 3 receptor (hH 3 R). Upon illumination, key compound 65 decreases its affinity for the hH 3 Rb y8 .5-fold and its potency in hH 3 R-mediated G i protein activation by over 20-fold, with the trans and cis isomer both acting as full agonist. In real-time two-electrode voltage clamp experiments in Xenopus oocytes, 65 shows rapid light-induced modulation of hH 3 Ra ctivity.L igand 65 shows good binding selectivity amongst the histamine receptor subfamily and has good photolytic stability.I na ll, 65 (VUF15000) is the first photoswitchable GPCR agonist confirmed to be modulated through its affinity and potency upon photoswitching while maintaining its intrinsic activity,r endering it an ew chemical biology tool for spatiotemporal control of GPCR activation.
Inr ecent years,p hotopharmacology has been gaining momentum as as trategy to optically control biochemical processes.
[1] Theu se of light as an external trigger to change ligand shape and consequently its pharmacological properties allows the probing of biological systems with great spatiotemporal resolution. [2] Theazobenzene moiety is often used in photoswitchable ligands [1a] due to its limited size,high photostability,a nd tunability of the absorption wavelength l max . [3] Its thermodynamically stable trans isomer typically involves af lat elongated structure,w hereas its photoinduced cis configuration has abent geometry with aconsiderably shorter end-to-end distance. [4] Whereas photopharmacology is well established in the field of enzyme and ion channel modulation, it is an upcoming technology for Gp rotein-coupled receptors (GPCRs). [1a] GPCRs constitute one of the largest families of transmembrane proteins,t heir dysfunction is associated with ap lethora of diseases and consequently GPCRs are one of the most successful classes of drug targets. [5] Recently,v arious GPCRs have been successfully targeted using photopharmacology approaches,i ncluding mopioid, [6] CXCR3, [7] CB1, [8] H 3 R, [9] mGlu5, [10] and GLP1. [11] Yet, almost all these examples include at least one but more frequently two antagonistic/partial agonist isomeric forms.In contrast, freely diffusible affinity and potencyp hotoswitches in which both isomers act as full agonists are scarce, [1a] even though such compounds would be very useful for photopharmacology approaches and complementary to agonist-toantagonist switches.
Theh istamine H 3 Rr eceptor is an intensively studied GPCR that is known to play an important role in sleep disorders and cognition-related diseases,such as Alzheimers and Parkinsonsd isease.T he first H 3 Ra ntagonist pitolisant (Wakix )h as been approved by the European Medicines
Agency for the treatment of narcolepsy. [12] Recently,w e published at oolbox of photoswitchable antagonists [9] that competitively inhibit histamine-induced H 3 Ra ctivity.I nt he current work, we aimed to develop high-potencyH 3 Rphotoswitchable agonists that can simplify spatiotemporal studies of the signaling network of the H 3 R. We disclose unique photoswitchable H 3 Ragonists that can be optically converted to isomers differing in their affinity and potency.
Thescaffold design was inspired by the hH 3 Rfull agonist VUF5980 previously published by our lab [13] (Figure 1 ). To date,virtually every published hH 3 Rfull agonist contains a4-substituted imidazole moiety combined with abasic or neutral side chain, as is the case for VUF5980. We left the imidazole portion of the molecule unchanged, and considered the diphenylacetylene moiety to be an attractive candidate for an "azologization" strategy. [3] Introducing the azobenzene at this position allows for great flexibility in the diversification of the scaffold. Based on the steep structure-activity relationship observed with VUF5980, [13] it was postulated that small changes would have significant impact on the affinity and potencyf or hH 3 R. Therefore,p rimarily the azobenzene was decorated with small substituents (i.e., methyl and fluorine groups) on both phenyl rings.
To synthesize the ligands,imidazole-4-carbaldehyde 2 was protected using N,N-dimethylsulfamoylchloride (DMS-Cl, Scheme 1) to afford 3,w hich was reduced to 4.A lcohol 4 was converted to chloride 5 using in situ mesylation. A diverse set of anilines 6-15 was oxidized to the corresponding nitrosobenzenes 16-25 using Oxone.A fter work-up,t hey were directly used in aM ills reaction with 3-amino-phenylboronic acid pinacol esters 26-32 to yield azobenzenepinacol esters 33-48. Cross coupling with chloride 5 afforded 49-64 in generally good yields.A cidic deprotection yielded final compounds 65-80,w hich were used for biological evaluation. [a] Adapted from Wijtmans et al. [13] [b] Determined at 25 mm in 50 mm Tris-HCl pH 7.4 buffer + 1% [D 6 ]DMSO.
[c] Thermalrelaxation half-life times, as determined by the method of Ahmed et al. [14] in 50 mm Tris-HCl pH 7.4 buffer + 1% [D 6 ]DMSO, extrapolating to 20 8 8C. Arrhenius plots are available in Figure S1 in the SupportingInformation.
[d] Photostationary state area percentages after illumination at 360 AE 20 nm at 1mm in [D 6 ]DMSO and as determined by LC-MS analysis at 254 nm. All pharmacologye xperiments were performed at least in triplicate.
Compounds 65-80 all have l max values for the p-p*t ransition of the trans isomer between 313 and 330 nm (Table 1) . The observed limited variation is due to the absence of strong electron-donating or -withdrawing substituents.S imilarly, l max values for the n-p*transition of the cis isomer differed marginally,r anging between 417 and 430 nm. Upon continuous illumination at 360 AE 20 nm, the values for the photostationary states (PSS) of 65-80 ranged from 92.3 to 97.5 % cis,e xcept for 69, which has 82.6 % cis.
Compounds 65-80 all showed slow thermal relaxation at room temperature (20 8 8C, Table 1 ). Theobserved thermal relaxation half-lives were impractically long for direct quantification, therefore extrapolations of high temperature thermal relaxation were used to quantify half-lives at 20 8 8C (Table 1and Supporting Information, Figure S1 ). [14] Compound 69 showed the fastest thermal relaxation in 50 mm Tr is-HCl pH 7.4 buffer, with ah alf-life of 26.6 days,w hile 72 showed the slowest relaxation, with ahalf-life of 147 days. Based on its favorable pharmacological profile (see below) and synthetic tractability,c ompound 65 was subjected to indepth photochemical characterization using 1 HN MR and LC-MS analysis during illumination at 360 AE 20 nm. Thew ellresolved signal of the benzylic CH 2 group provided ac lear handle for quantification in 1 HN MR analysis (Figure 2A ). An overestimation of isomerization percentage is observed in LC-MS analysis at 254 nm compared to 1 HN MR analysis ( Figure 2B and Supporting Information, Table S1 ), which can be explained by the differences in extinction coefficients for the trans and cis isomer at 254 nm ( Figure 2C and Supporting Information, Figures S2 and S3) . Compound 65 showed excellent resistance to photobleaching during more than 1000 isomerization cycles ( Figure 2D ). Thed ynamic isomerization was studied using UV/Vis spectroscopy under alternating illumination ( Figure 2E Thelong thermal relaxation half-lives allowed for detailed pharmacological evaluation using hH 3 Rc ompetition binding as well as functional experiments.F or this,t he compound solutions were either illuminated at 360 AE 20 nm to reach aPSS cis or kept in the dark to ensure more than 99 % trans isomer.T he affinity of both isomers for the hH 3 Rw as assessed in competition binding with [ 3 H]-N a -methylhistamine (NAMH). All compounds displayed hH 3 Rb inding affinity,w hich decreased upon illumination, reaching up to a2 1-fold affinity difference in the case of 76.I nt erms of absolute affinity, 65 displayed the highest affinities for the hH 3 Rwith apK i value of 8.42 AE 0.04 for its trans isomer and apK i value of 7.49 AE 0.05 for its cis isomer,resulting in an 8.5-fold shift upon illumination ( Figure 3A and Table 1 ). Fluorine-substituted analogues 67 and 80 performed similarly to 65 in competition binding,displaying only amarginally lower affinity (Table 1) . Notably, para-methyl substitution on the R 1 Figure 2 . A) Representative part of 1 HNMR spectra of 10 mm 65 in [D 6 ]DMSO illuminated at 360 AE 20 nm displayed at various time points (seconds). The presented peak belongs to the hydrogen atoms explicitly drawn in the structure shown above the spectrum. Full spectra are available in Figure S4 in the SupportingI nformation. B) Representativepart of LC-MS chromatograms belonging to the illuminated NMR sample in Figure 2A .F ull chromatogramsa re available in Figure S5 position (78)decreased the binding affinity and abrogated the photoisomerization-induced affinity shift compared to 65 (Table 1) . Reduction of the size of the para-substituents to either chlorine (71)o rf luorine (68)m oieties gradually rescued hH 3 Ra ffinity and reestablished the shift in affinity to 6-and 15-fold, respectively.Methylation at either the ortho (76)ormeta (77)position of R 1 still resulted in decent binding affinities and high (21-fold) to good (8.5-fold) affinity shifts upon illumination. Addition of substituents at the R 2 position resulted in aclear affinity cliff,with fluorine substitutions (79 and 80)s till being allowed, but the addition of am ethyl substituent (72-75)h ighly decreases the binding affinity of the cis isomer.Moreover,for the trans isomers,4-Me (73)and 6-Me (75)s ubstitution was still tolerated yet showed al ogunit decrease in hH 3 Ra ffinity compared to 65,w hile 2-Me (72)a nd 5-Me (74)g roups highly reduced hH 3 Ra ffinity and consequently reduced or even abolished (72)the affinity shift (Table 1) .
Based on the observed affinities and photo-induced affinity shifts,t he efficacyi ns timulating hH 3 R-mediated G i protein activation was evaluated for ligands 65 and 76 in a[
35 S]-GTPgSb inding assay.T he highest-affinity ligand 65 (pK i trans = 8.42 AE 0.04) also displayed the highest potency (pEC 50 trans = 7.60 AE 0.13) to induce G i activation, which upon photoisomerization decreased 20-fold (pEC 50 at PSS cis: 6.30 AE 0.13), with both isomers being full agonists and having intrinsic activities of a = 1.0 AE 0.03, compared to histamine ( Figure 3B ). Since the observed shift in hH 3 Raffinity was 8.5-fold, the larger (20-fold) shift in functional potencyindicates that for 65 the efficacy(propensity to activate aGPCR [15] )is also affected upon trans-cis isomerization. Interestingly, al arge photo-induced decrease in potencyo f2 3-fold was also obtained for 76 (pEC 50 trans:6.78 AE 0.11, PSS cis:5.41 AE 0.11, a = 1.00 AE 0.0). This shift in potencyof76 is completely explained by the observed change of its affinity (see above).
Compound 65 (VUF15 000) was selected as tool compound for further analysis,asithas good synthetic tractability and its superior potencyi saclear advantage for pharmacological studies.A sthei midazole-based pharmacophore/scaffold used in the design of these photoswitchable ligands is prone to interact with other histamine receptor subtypes, [13] 65 was tested for its subtype selectivity.Binding of 65 was more than 300-fold selective for hH 3 Ro ver hH 1 Ra nd hH 2 R (Supporting Information, Table S2 ), while a3 0-fold selectivity was observed over its closest homologue hH 4 R( Supporting Information, Table S2 ). Interestingly, 65 displayed high nm (trans)t ol ow mm (PSS cis)b inding affinities for both mouse and rat H 3 R, with a4 -fold and 8-fold shift in binding affinity upon photoisomerization, respectively (Supporting Information, Table S2 ).
Real-time photomodulation of hH 3 Ra ctivity by 65 was measured using two-electrode voltage clamp (TEVC) experiments on Xenopus laevis oocytes expressing both hH 3 Rand G protein-coupled inwardly rectifying potassium (GIRK)-channels ( Figure 3C ). In this expression system, histamine application resulted in hH 3 R-mediated GIRK activation, which was insensitive to optical modulation. [9] As expected based on our data with the [
35 S]-GTPgSbinding assay, trans-65 elicited an agonistic response in this system, which could be reduced by switching to the less active cis isomer upon illumination at 360 AE 20 nm. Retrieval of the agonistic response could be provoked by either actively switching the cis isomer back into its trans isomer by illuminating at 434 AE 9nmo rb ys topping illumination, due to continuous perfusion of the trans isomer ( Figure 3D ). Dynamic photoswitching of 65 could be performed repeatedly,i llustrating that the use of two specific wavelengths allows optical control of the hH 3 Ra ctivation mediated by 65.F urthermore,p hotoswitchable agonist 65 showed rapid hH 3 Ra ctivation and deactivation kinetics, aiding in its use in in vivo experimentation.
In summary,w eh ave synthesized and characterized 16 photoswitchable hH 3 Ragonists that change their affinity and potencyu pon illumination, indicating as uccessful azologization strategy.All possess long thermal relaxation half-lives at room temperature making them useful for av ariety of pharmacological studies.C ompound 65 (VUF15 000) was selected as key compound on the basis of synthetic tractability and highest absolute hH 3 Ra ffinity.M oreover,u pon illumination, 65 displays ahigh potencyand a20-fold potency shift, while maintaining full intrinsic activity in G i protein activation, making it especially attractive as atool compound. With a20-fold shift in potency, 65 is one of the best photoswitchable GPCR agonists reported so far. Electrophysiology experiments showed the dynamic optical modulation of hH 3 R activation induced by 65 in real time,s etting the stage for further unraveling of the downstream signaling of hH 3 Rwith great spatiotemporal precision. Recently,p hotopharmacology approaches with freely diffusible GPCR ligands have,for the first time,b een used successfully in vivo to modulate tadpole and zebrafish behavior [10, 16] and to elucidate the role of the metabotropic glutamate receptor 4i nt he nervous system using amouse model of chronic pain. [17] In view of the widespread distribution of the H 3 Ri nt he central and peripheral nervous system, photopharmacology approaches with tools such as 65 offer new means (complementary to optogenetic approaches [18] )t oi nvestigate the spatial and temporal details of H 3 Rm odulation of important processes, for example,arousal, cognition and neuropathic pain.
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